Curis, Inc. to Present at the 30th Annual Cowen and Company Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 30th Annual Cowen Healthcare Conference at 4:00 p.m. EST on March 8, 2010, in Boston, Massachusetts.

Back to news